Class II · Moderate risk
Lacosamide Tablets
CGMP Deviations
FDA Drug Recalls
18,003 recalls, newest first
Class II · Moderate risk
Carvedilol Tablets
CGMP Deviations
Class II · Moderate risk
Ranolazine Extended-Release Tablets 1000mg
CGMP Deviations
Class II · Moderate risk
Teriflunomide Tablets
CGMP Deviations
Class II · Moderate risk
Solifenacin Succinate Tablets 5mg
CGMP Deviations
Class II · Moderate risk
Saxagliptin Tablets 5mg
CGMP Deviations
Class II · Moderate risk
Nitroglycerin Sublingual Tablets 0.3MG
CGMP Deviations
Class II · Moderate risk
Lacosamide Tablets
CGMP Deviations
Class II · Moderate risk
Indomethacin Extended-Release Capsules
CGMP Deviations
Class II · Moderate risk
Metformin Hydrochloride Extended-Release Tablets 1000mg
CGMP Deviations
Class II · Moderate risk
Fluphenazine Hydrochloride Tablets 2.5mg
CGMP Deviations
Class II · Moderate risk
Fluphenazine Hydrochloride Tablets
CGMP Deviations
Class II · Moderate risk
Pravastatin Sodium Tablets 80mg
CGMP Deviations
Class II · Moderate risk
Nitroglycerin Sublingual Tablets 0.4MG 100-count carton
CGMP Deviations
Class II · Moderate risk
Rufinamide Tablets 200mg
CGMP Deviations
Class II · Moderate risk
Frovatriptan Succinate Tablets 2.5mg
CGMP Deviations
Class II · Moderate risk
Lacosamide Tablets 200mg
CGMP Deviations
Class II · Moderate risk
Gabapentin Tablets 600mg
CGMP Deviations
Class II · Moderate risk
Voriconazole Tablets 50mg
CGMP Deviations
Class II · Moderate risk
Voriconazole Tablets 200 mg
CGMP Deviations
Class II · Moderate risk
Solifenacin Succinate Tablets 10MG
CGMP Deviations
Class II · Moderate risk
Propafenone Hydrochloride Extended-Release Capsules 325mg
CGMP Deviations
Class II · Moderate risk
Propafenone Hydrochloride Extended-Release Capsules 225mg
CGMP Deviations
Class II · Moderate risk
Fenofibrate Capsules 67 mg
CGMP Deviations
Class II · Moderate risk
In Your Face Mineral Tint SPF 31
cGMP deviations